Genomic Vision Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2022
For the full year Total revenue from activity was 1,480,000 against 1,413,000 reported a year ago.
1st Jan change | Capi. | |
---|---|---|
+2.42% | 42.75B | |
+47.70% | 41.61B | |
+12.09% | 41.34B | |
-8.83% | 26.59B | |
+6.84% | 25.49B | |
-22.84% | 18.12B | |
+30.41% | 12.24B | |
-2.08% | 11.76B | |
+9.14% | 11B |